Chinese drug developer Antengene wins backing from the likes of Boyu Capital and FountainVest Partners for a pipeline of treatments that address the country's growing cancer problem
Despite being the world’s second-largest pharmaceutical market, China isn’t known for its prowess in drug innovation. The country has some of the highest incidence rates for cancer, diabetes and liver...
Apis Partners has agreed to invest up to $110 million in L&T Infra Debt Fund (L&T IDF), a subsidiary of India’s L&T Finance Holdings focused on financing infrastructure projects in India.
Omnivore Partners, an Indian venture capital firm focused on impact investment in the local agriculture industry, has closed its second early-stage fund with $97 million in commitments.
CDIB Capital has invested an undisclosed amount in VHQ China, a Taiwan-based provider of post-production and visual effects services focused on China’s film and TV drama industry.
Tongdun Technology, a Chinese risk control services provider, has raised $100 million in a new round of funding led by CMC Capital, GGV Capital, China Everbright Limited and Guotai Global Investments. Existing investor Cinda Sinorock Capital also participated.